Skip to main content
Clinical Trials/ACTRN12618000731291
ACTRN12618000731291
Completed
N/A

Evaluation of a multi-component educational package for GP registrars in reviewing older patients’ medication regimens and deprescribing inappropriate medications: a pragmatic evaluation employing non-equivalent control group design, nested within an ongoing cohort study.

Professor Parker Magin0 sites624 target enrollmentMay 2, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Polypharmacy
Sponsor
Professor Parker Magin
Enrollment
624
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 2, 2018
End Date
February 15, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Parker Magin

Eligibility Criteria

Inclusion Criteria

  • For the analysis using ReCEnT study data:
  • Intervention group: Registrars in Terms 1 and 2 of their vocational training program at one RTO (GP Synergy)
  • Control group: Registrars in Terms 1 and 2 of their vocational training program at two RTOs (General Practice Training Tasmania – GPTT; and Eastern Victoria GP Training\- EVGP)
  • For the questionnaire\-based study:
  • Registrars in Terms 1 and 2 of their vocational training program at one RTO (GP Synergy) at the commencement of the study
  • For the qualitative study:
  • Registrars in Terms 1 and 2 of their vocational training program at one RTO (GP Synergy) who have attended the workshop intervention and supervisors (who have attended the webinar intervention) of GP Synergy registrars

Exclusion Criteria

  • For the analysis using ReCEnT study data:
  • Registrars who do not provide consent for the data they collect as part of the ReCEnT project to be used for research purposes.
  • For the questionnaire\-based study:
  • No exclusions
  • For the qualitative study:
  • Registrars or supervisors who have not attended the workshop or webinar
  • Registrars or supervisors who have not attended the workshop or webinar

Outcomes

Primary Outcomes

Not specified

Similar Trials